These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 23295253

  • 1. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK, Ott SR, Geiser T.
    Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of mycophenolate mofetil in sarcoidosis.
    Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA.
    Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
    Androdias G, Maillet D, Marignier R, Pinède L, Confavreux C, Broussolle C, Vukusic S, Sève P.
    Neurology; 2011 Mar 29; 76(13):1168-72. PubMed ID: 21444902
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
    Papiris S, Stagaki E, Papadaki G, Kolilekas L, Korbila I, Apollonatou V, Kallieri M, Gialafos H, Chatziioannou S, Papaioannou AI, Manali ED.
    Pulm Pharmacol Ther; 2019 Oct 29; 58():101840. PubMed ID: 31518648
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
    Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M.
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul 29; 244(7):788-94. PubMed ID: 16163494
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep 29; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 7. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar 29; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Mar 15; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 12. Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Tang CS, Chan TM.
    Rheumatology (Oxford); 2013 Mar 15; 52(3):480-6. PubMed ID: 23148090
    [Abstract] [Full Text] [Related]

  • 13. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 14. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
    Greiner K, Varikkara M, Santiago C, Forrester JV.
    Ophthalmologe; 2002 Sep 15; 99(9):691-4. PubMed ID: 12219257
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
    Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):524S-527S. PubMed ID: 15041401
    [Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar 15; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M, Jayne DR.
    Nephron Clin Pract; 2006 Mar 15; 102(3-4):c100-7. PubMed ID: 16286784
    [Abstract] [Full Text] [Related]

  • 20. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A.
    Actas Dermosifiliogr; 2009 Dec 15; 100(10):883-7. PubMed ID: 20038365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.